 Jeffrey Brent
Concepts (288)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Poisoning | 21 | 2025 | 120 | 3.680 |
Why?
| | Drug Overdose | 25 | 2025 | 347 | 3.140 |
Why?
| | Toxicology | 14 | 2025 | 48 | 2.750 |
Why?
| | Registries | 31 | 2025 | 2035 | 1.900 |
Why?
| | Analgesics, Opioid | 23 | 2025 | 1000 | 1.860 |
Why?
| | Methanol | 4 | 2021 | 38 | 1.530 |
Why?
| | Ethylene Glycol | 5 | 2022 | 13 | 1.350 |
Why?
| | Antidotes | 8 | 2023 | 143 | 1.330 |
Why?
| | Emergency Service, Hospital | 21 | 2025 | 2069 | 1.250 |
Why?
| | Acidosis | 3 | 2022 | 101 | 1.070 |
Why?
| | Tramadol | 6 | 2024 | 14 | 1.030 |
Why?
| | Cannabinoids | 3 | 2022 | 161 | 0.920 |
Why?
| | Decontamination | 2 | 2014 | 30 | 0.840 |
Why?
| | Cocaine | 2 | 2022 | 166 | 0.830 |
Why?
| | Burns, Chemical | 2 | 2014 | 32 | 0.830 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 7 | 2018 | 250 | 0.810 |
Why?
| | Bias | 1 | 2024 | 218 | 0.810 |
Why?
| | Snake Bites | 5 | 2022 | 29 | 0.800 |
Why?
| | Butterflies | 1 | 2023 | 21 | 0.790 |
Why?
| | Substance-Related Disorders | 7 | 2025 | 1083 | 0.790 |
Why?
| | Mesothelioma | 1 | 2023 | 44 | 0.790 |
Why?
| | Opiate Alkaloids | 1 | 2022 | 7 | 0.790 |
Why?
| | Moths | 1 | 2023 | 45 | 0.780 |
Why?
| | Fentanyl | 6 | 2024 | 94 | 0.740 |
Why?
| | Poisons | 1 | 2021 | 23 | 0.720 |
Why?
| | Pyrazoles | 4 | 2021 | 423 | 0.710 |
Why?
| | Abortion, Induced | 1 | 2022 | 105 | 0.660 |
Why?
| | Referral and Consultation | 9 | 2025 | 786 | 0.650 |
Why?
| | Cobalt | 2 | 2017 | 52 | 0.650 |
Why?
| | Hip Prosthesis | 2 | 2017 | 46 | 0.640 |
Why?
| | Skin | 2 | 2014 | 752 | 0.600 |
Why?
| | Metformin | 1 | 2022 | 331 | 0.570 |
Why?
| | Hypoglycemia | 2 | 2022 | 445 | 0.560 |
Why?
| | Metal-on-Metal Joint Prostheses | 1 | 2017 | 2 | 0.560 |
Why?
| | Chromium | 1 | 2017 | 15 | 0.560 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2017 | 177 | 0.540 |
Why?
| | Humans | 80 | 2025 | 137585 | 0.530 |
Why?
| | Prospective Studies | 22 | 2025 | 7604 | 0.510 |
Why?
| | United States | 29 | 2025 | 14841 | 0.510 |
Why?
| | Suicide, Attempted | 5 | 2024 | 378 | 0.500 |
Why?
| | Chelating Agents | 3 | 2021 | 75 | 0.480 |
Why?
| | Adult | 42 | 2025 | 37929 | 0.470 |
Why?
| | Chelation Therapy | 2 | 2013 | 11 | 0.460 |
Why?
| | Substance Abuse Detection | 4 | 2025 | 87 | 0.440 |
Why?
| | Benzodiazepines | 3 | 2025 | 155 | 0.430 |
Why?
| | Mercury Poisoning, Nervous System | 1 | 2013 | 3 | 0.430 |
Why?
| | Middle Aged | 34 | 2025 | 33479 | 0.420 |
Why?
| | Central Nervous System Stimulants | 2 | 2025 | 161 | 0.420 |
Why?
| | Bupropion | 2 | 2024 | 45 | 0.410 |
Why?
| | Child Development Disorders, Pervasive | 1 | 2013 | 62 | 0.410 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1040 | 0.410 |
Why?
| | Inappropriate Prescribing | 1 | 2013 | 55 | 0.410 |
Why?
| | Young Adult | 25 | 2025 | 13209 | 0.400 |
Why?
| | Decision Support Techniques | 1 | 2017 | 421 | 0.400 |
Why?
| | Male | 46 | 2025 | 67762 | 0.380 |
Why?
| | Narcotic Antagonists | 6 | 2025 | 181 | 0.380 |
Why?
| | Naloxone | 8 | 2025 | 122 | 0.370 |
Why?
| | Antivenins | 4 | 2022 | 36 | 0.370 |
Why?
| | Paraquat | 1 | 2011 | 14 | 0.370 |
Why?
| | Herbicides | 1 | 2011 | 27 | 0.360 |
Why?
| | Parkinsonian Disorders | 1 | 2011 | 35 | 0.360 |
Why?
| | Female | 45 | 2025 | 73304 | 0.340 |
Why?
| | Methadone | 3 | 2020 | 101 | 0.330 |
Why?
| | Hallucinogens | 2 | 2023 | 105 | 0.330 |
Why?
| | Opioid-Related Disorders | 3 | 2024 | 515 | 0.330 |
Why?
| | Analgesics, Non-Narcotic | 3 | 2023 | 125 | 0.330 |
Why?
| | Pharmacovigilance | 3 | 2024 | 23 | 0.320 |
Why?
| | Aged | 19 | 2023 | 23961 | 0.310 |
Why?
| | Child | 24 | 2025 | 21935 | 0.300 |
Why?
| | Adolescent | 23 | 2025 | 21513 | 0.300 |
Why?
| | Child, Preschool | 17 | 2025 | 11074 | 0.270 |
Why?
| | Time Factors | 9 | 2025 | 6828 | 0.270 |
Why?
| | Treatment Outcome | 10 | 2020 | 10811 | 0.240 |
Why?
| | Seizures | 3 | 2021 | 426 | 0.230 |
Why?
| | Edema | 2 | 2023 | 130 | 0.230 |
Why?
| | Intubation, Intratracheal | 2 | 2025 | 257 | 0.230 |
Why?
| | Cannabis | 2 | 2023 | 494 | 0.230 |
Why?
| | Drug Contamination | 1 | 2024 | 53 | 0.230 |
Why?
| | Infant | 13 | 2025 | 9465 | 0.220 |
Why?
| | Patient Outcome Assessment | 1 | 2025 | 131 | 0.220 |
Why?
| | Plant Poisoning | 1 | 2023 | 9 | 0.210 |
Why?
| | Anticonvulsants | 3 | 2022 | 217 | 0.210 |
Why?
| | Cohort Studies | 10 | 2024 | 5742 | 0.210 |
Why?
| | Fat Emulsions, Intravenous | 1 | 2023 | 30 | 0.210 |
Why?
| | Adenosine Monophosphate | 1 | 2024 | 66 | 0.210 |
Why?
| | Talc | 1 | 2023 | 9 | 0.210 |
Why?
| | Predictive Value of Tests | 4 | 2017 | 2031 | 0.200 |
Why?
| | Self-Injurious Behavior | 1 | 2024 | 130 | 0.200 |
Why?
| | Alanine | 1 | 2024 | 152 | 0.200 |
Why?
| | Metals, Heavy | 2 | 2021 | 31 | 0.200 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 310 | 0.200 |
Why?
| | Amphetamines | 1 | 2022 | 5 | 0.200 |
Why?
| | Psychotropic Drugs | 4 | 2023 | 68 | 0.200 |
Why?
| | Prescription Drug Misuse | 2 | 2021 | 41 | 0.200 |
Why?
| | Intensive Care Units, Pediatric | 1 | 2025 | 233 | 0.200 |
Why?
| | Diphenhydramine | 1 | 2022 | 37 | 0.190 |
Why?
| | Foodborne Diseases | 1 | 2023 | 57 | 0.190 |
Why?
| | Ivermectin | 1 | 2022 | 13 | 0.190 |
Why?
| | Snakes | 2 | 2022 | 21 | 0.190 |
Why?
| | Narcotics | 1 | 2022 | 52 | 0.190 |
Why?
| | Caffeine | 1 | 2022 | 68 | 0.190 |
Why?
| | Larva | 1 | 2023 | 226 | 0.190 |
Why?
| | Vertigo | 1 | 2022 | 39 | 0.190 |
Why?
| | Hydroxychloroquine | 1 | 2022 | 58 | 0.190 |
Why?
| | Sulfonylurea Compounds | 1 | 2022 | 48 | 0.190 |
Why?
| | Nausea | 1 | 2022 | 111 | 0.180 |
Why?
| | Tremor | 1 | 2022 | 65 | 0.180 |
Why?
| | Patient Reported Outcome Measures | 1 | 2025 | 402 | 0.180 |
Why?
| | Dizziness | 1 | 2022 | 82 | 0.180 |
Why?
| | Acetaminophen | 2 | 2022 | 268 | 0.180 |
Why?
| | Vomiting | 1 | 2022 | 130 | 0.180 |
Why?
| | Diarrhea | 1 | 2022 | 184 | 0.170 |
Why?
| | Coral Snakes | 1 | 2020 | 3 | 0.170 |
Why?
| | Elapid Venoms | 1 | 2020 | 18 | 0.170 |
Why?
| | Abdominal Pain | 1 | 2022 | 145 | 0.170 |
Why?
| | Research Personnel | 4 | 2022 | 173 | 0.170 |
Why?
| | Analgesics | 1 | 2022 | 206 | 0.170 |
Why?
| | Eating | 1 | 2023 | 380 | 0.170 |
Why?
| | Risk Factors | 7 | 2024 | 10388 | 0.160 |
Why?
| | Crotalus | 1 | 2020 | 26 | 0.160 |
Why?
| | Patient-Centered Care | 1 | 2025 | 530 | 0.160 |
Why?
| | Crotalid Venoms | 1 | 2020 | 31 | 0.160 |
Why?
| | Creatinine | 1 | 2022 | 499 | 0.160 |
Why?
| | Rhabdomyolysis | 1 | 2019 | 21 | 0.160 |
Why?
| | Nicotine | 1 | 2022 | 334 | 0.160 |
Why?
| | Blood Chemical Analysis | 2 | 2010 | 99 | 0.150 |
Why?
| | Retrospective Studies | 7 | 2024 | 15657 | 0.150 |
Why?
| | Heavy Metal Poisoning | 2 | 2021 | 3 | 0.150 |
Why?
| | Prevalence | 3 | 2024 | 2734 | 0.150 |
Why?
| | Loperamide | 1 | 2018 | 11 | 0.150 |
Why?
| | Antidepressive Agents | 3 | 2016 | 236 | 0.150 |
Why?
| | Antidiarrheals | 1 | 2018 | 15 | 0.150 |
Why?
| | Hearing Loss, Sensorineural | 1 | 2019 | 67 | 0.150 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2023 | 394 | 0.150 |
Why?
| | Biomedical Research | 1 | 2025 | 692 | 0.150 |
Why?
| | Annual Reports as Topic | 1 | 2018 | 3 | 0.150 |
Why?
| | Crime | 1 | 2019 | 60 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 654 | 0.150 |
Why?
| | Animals | 10 | 2023 | 36940 | 0.150 |
Why?
| | Viperidae | 1 | 2018 | 7 | 0.150 |
Why?
| | Hospital Mortality | 4 | 2025 | 911 | 0.140 |
Why?
| | Biomarkers | 4 | 2022 | 4149 | 0.140 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2018 | 59 | 0.140 |
Why?
| | Israel | 2 | 2017 | 56 | 0.140 |
Why?
| | Prognosis | 4 | 2022 | 4030 | 0.140 |
Why?
| | Drug Misuse | 1 | 2017 | 1 | 0.140 |
Why?
| | London | 1 | 2017 | 47 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2019 | 162 | 0.140 |
Why?
| | Aged, 80 and over | 7 | 2019 | 7635 | 0.140 |
Why?
| | Pediatrics | 3 | 2018 | 1101 | 0.130 |
Why?
| | Brain Death | 1 | 2017 | 46 | 0.130 |
Why?
| | Neurologic Examination | 1 | 2017 | 110 | 0.130 |
Why?
| | Crime Victims | 1 | 2019 | 127 | 0.130 |
Why?
| | Bicarbonates | 2 | 2022 | 44 | 0.130 |
Why?
| | Designer Drugs | 1 | 2016 | 8 | 0.130 |
Why?
| | Prosthesis Failure | 1 | 2017 | 123 | 0.130 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2018 | 179 | 0.130 |
Why?
| | Disease Outbreaks | 1 | 2019 | 395 | 0.120 |
Why?
| | North America | 3 | 2022 | 313 | 0.120 |
Why?
| | Chronic Pain | 1 | 2019 | 262 | 0.110 |
Why?
| | Odds Ratio | 1 | 2017 | 1070 | 0.110 |
Why?
| | Pregnancy | 3 | 2023 | 6763 | 0.110 |
Why?
| | Hypnotics and Sedatives | 1 | 2016 | 200 | 0.110 |
Why?
| | Body Burden | 1 | 2013 | 8 | 0.110 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 815 | 0.110 |
Why?
| | Hospitalization | 4 | 2022 | 2199 | 0.110 |
Why?
| | Length of Stay | 2 | 2025 | 1215 | 0.110 |
Why?
| | Tertiary Care Centers | 1 | 2015 | 160 | 0.110 |
Why?
| | Hydrofluoric Acid | 1 | 2013 | 8 | 0.110 |
Why?
| | Urinalysis | 1 | 2013 | 77 | 0.100 |
Why?
| | Unnecessary Procedures | 1 | 2013 | 50 | 0.100 |
Why?
| | Poison Control Centers | 2 | 2015 | 90 | 0.100 |
Why?
| | Chromatography, Liquid | 2 | 2025 | 433 | 0.100 |
Why?
| | Reproducibility of Results | 2 | 2021 | 3284 | 0.100 |
Why?
| | International Cooperation | 1 | 2013 | 198 | 0.100 |
Why?
| | Alanine Transaminase | 2 | 2024 | 157 | 0.100 |
Why?
| | Hypoglycemic Agents | 1 | 2022 | 1291 | 0.100 |
Why?
| | Data Mining | 1 | 2013 | 116 | 0.100 |
Why?
| | Australia | 1 | 2013 | 315 | 0.100 |
Why?
| | Ethanol | 2 | 2023 | 608 | 0.100 |
Why?
| | Canada | 1 | 2013 | 418 | 0.100 |
Why?
| | Organic Chemicals | 1 | 2013 | 124 | 0.090 |
Why?
| | Coma | 2 | 2023 | 32 | 0.090 |
Why?
| | Renal Dialysis | 2 | 2019 | 435 | 0.090 |
Why?
| | Hospitals, Pediatric | 1 | 2015 | 508 | 0.090 |
Why?
| | Cooperative Behavior | 1 | 2013 | 451 | 0.090 |
Why?
| | Glycols | 1 | 2010 | 7 | 0.080 |
Why?
| | Ethylenes | 1 | 2010 | 9 | 0.080 |
Why?
| | Ethylene Glycols | 1 | 2010 | 16 | 0.080 |
Why?
| | Pregnancy Complications | 1 | 2015 | 527 | 0.080 |
Why?
| | Compensation and Redress | 1 | 2010 | 8 | 0.080 |
Why?
| | Consultants | 1 | 2010 | 13 | 0.080 |
Why?
| | Half-Life | 1 | 2010 | 164 | 0.080 |
Why?
| | Blood Glucose | 1 | 2020 | 2186 | 0.080 |
Why?
| | Water | 1 | 2013 | 460 | 0.080 |
Why?
| | Injections, Intravenous | 1 | 2010 | 206 | 0.080 |
Why?
| | HIV Infections | 1 | 2024 | 2836 | 0.080 |
Why?
| | Disease Progression | 2 | 2023 | 2757 | 0.080 |
Why?
| | Societies, Medical | 1 | 2013 | 820 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2013 | 740 | 0.080 |
Why?
| | Osmolar Concentration | 1 | 2009 | 171 | 0.080 |
Why?
| | Buprenorphine | 2 | 2025 | 173 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2017 | 2828 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2013 | 1050 | 0.070 |
Why?
| | Infant, Newborn | 3 | 2020 | 6079 | 0.070 |
Why?
| | Survivors | 1 | 2011 | 493 | 0.070 |
Why?
| | Databases, Factual | 3 | 2017 | 1357 | 0.060 |
Why?
| | Missouri | 1 | 2024 | 61 | 0.060 |
Why?
| | Pennsylvania | 1 | 2024 | 116 | 0.060 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2024 | 45 | 0.050 |
Why?
| | Outpatients | 2 | 2021 | 396 | 0.050 |
Why?
| | Health Personnel | 1 | 2010 | 710 | 0.050 |
Why?
| | Alcoholism | 1 | 2010 | 807 | 0.050 |
Why?
| | Inpatients | 2 | 2021 | 500 | 0.050 |
Why?
| | Xylazine | 1 | 2023 | 14 | 0.050 |
Why?
| | Piperidines | 1 | 2024 | 206 | 0.050 |
Why?
| | Phenacetin | 1 | 2022 | 1 | 0.050 |
Why?
| | Alprazolam | 1 | 2022 | 6 | 0.050 |
Why?
| | Lactic Acid | 1 | 2024 | 305 | 0.050 |
Why?
| | Codeine | 1 | 2022 | 6 | 0.050 |
Why?
| | Bradycardia | 1 | 2023 | 55 | 0.050 |
Why?
| | Risk Assessment | 3 | 2019 | 3457 | 0.050 |
Why?
| | Glycolates | 1 | 2022 | 5 | 0.050 |
Why?
| | Levamisole | 1 | 2022 | 19 | 0.050 |
Why?
| | Sucrose | 1 | 2022 | 110 | 0.050 |
Why?
| | Heroin | 1 | 2022 | 31 | 0.050 |
Why?
| | Chloroquine | 1 | 2022 | 54 | 0.050 |
Why?
| | Age Factors | 2 | 2020 | 3295 | 0.050 |
Why?
| | United States Food and Drug Administration | 1 | 2023 | 208 | 0.050 |
Why?
| | Attitude of Health Personnel | 1 | 2010 | 1171 | 0.050 |
Why?
| | Patient Participation | 1 | 2025 | 420 | 0.050 |
Why?
| | Quercetin | 1 | 2021 | 15 | 0.050 |
Why?
| | Diazepam | 1 | 2021 | 35 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2025 | 5472 | 0.040 |
Why?
| | Benzimidazoles | 1 | 2022 | 170 | 0.040 |
Why?
| | Practice Guidelines as Topic | 1 | 2009 | 1587 | 0.040 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2020 | 46 | 0.040 |
Why?
| | Erythema | 1 | 2020 | 29 | 0.040 |
Why?
| | Paresthesia | 1 | 2020 | 15 | 0.040 |
Why?
| | Iron | 1 | 2022 | 313 | 0.040 |
Why?
| | Antiemetics | 1 | 2020 | 43 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2021 | 455 | 0.040 |
Why?
| | Texas | 1 | 2020 | 244 | 0.040 |
Why?
| | Emergency Treatment | 1 | 2021 | 118 | 0.040 |
Why?
| | Alcoholic Beverages | 1 | 2019 | 28 | 0.040 |
Why?
| | Weapons of Mass Destruction | 1 | 2018 | 1 | 0.040 |
Why?
| | Research Design | 1 | 2025 | 1139 | 0.040 |
Why?
| | Atrioventricular Block | 1 | 2018 | 37 | 0.040 |
Why?
| | Antiviral Agents | 1 | 2024 | 744 | 0.030 |
Why?
| | Long QT Syndrome | 1 | 2018 | 70 | 0.030 |
Why?
| | Retreatment | 1 | 2017 | 72 | 0.030 |
Why?
| | Demography | 1 | 2018 | 291 | 0.030 |
Why?
| | Critical Illness | 1 | 2023 | 811 | 0.030 |
Why?
| | Opiate Substitution Treatment | 1 | 2019 | 155 | 0.030 |
Why?
| | Triage | 1 | 2019 | 222 | 0.030 |
Why?
| | Toxiferine | 1 | 2016 | 1 | 0.030 |
Why?
| | Respiratory Insufficiency | 1 | 2020 | 318 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2020 | 347 | 0.030 |
Why?
| | Sentinel Surveillance | 1 | 2016 | 49 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2016 | 51 | 0.030 |
Why?
| | Pharmaceutical Preparations | 1 | 2018 | 179 | 0.030 |
Why?
| | Arrhythmias, Cardiac | 1 | 2018 | 333 | 0.030 |
Why?
| | Medicare | 1 | 2021 | 773 | 0.030 |
Why?
| | Patient Admission | 1 | 2017 | 197 | 0.030 |
Why?
| | Electrocardiography | 1 | 2018 | 629 | 0.030 |
Why?
| | Nonprescription Drugs | 1 | 2015 | 63 | 0.030 |
Why?
| | Pain | 1 | 2020 | 756 | 0.030 |
Why?
| | Pandemics | 1 | 2023 | 1639 | 0.030 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2015 | 96 | 0.030 |
Why?
| | Colorado | 1 | 2024 | 4565 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2017 | 322 | 0.030 |
Why?
| | Program Evaluation | 1 | 2017 | 898 | 0.020 |
Why?
| | Device Removal | 1 | 2013 | 136 | 0.020 |
Why?
| | Oxycodone | 1 | 2012 | 42 | 0.020 |
Why?
| | Acute Disease | 1 | 2015 | 1007 | 0.020 |
Why?
| | Rats | 1 | 2021 | 5647 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3556 | 0.020 |
Why?
| | Acetylcysteine | 1 | 2012 | 145 | 0.020 |
Why?
| | Cardiovascular Diseases | 1 | 2024 | 2111 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2013 | 327 | 0.020 |
Why?
| | Health Promotion | 1 | 2017 | 741 | 0.020 |
Why?
| | Cardiovascular Agents | 1 | 2012 | 159 | 0.020 |
Why?
| | Antipsychotic Agents | 1 | 2012 | 194 | 0.020 |
Why?
| | Administration, Oral | 1 | 2012 | 816 | 0.020 |
Why?
| | Emergency Medical Services | 1 | 2015 | 552 | 0.020 |
Why?
| | Data Collection | 1 | 2011 | 673 | 0.020 |
Why?
| | Incidence | 1 | 2012 | 2804 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2010 | 5778 | 0.010 |
Why?
|
|
Brent's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|